UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000014299
Receipt number	R000016650
Scientific Title	Phase II study of erlotinib monotherapy for patients with advanced stage of non-small cell lung cancer, undetectable epidermal growth factor receptor (EGFR) mutations by PNA LNA PCR clamp method, but positive immuno-staining with anti-EGFR mutation-specific antibodies.
Date of disclosure of the study information	2014/07/01
Last modified on	2016/08/05 13:23:11

---